Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Medtronic
McKinsey
Baxter
Colorcon

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

DIETHYLPROPION HYDROCHLORIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Diethylpropion Hydrochloride, and what generic alternatives are available?

Diethylpropion Hydrochloride is a drug marketed by Lannett Co Inc, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs. and is included in ten NDAs.

The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.

Drug patent expirations by year for DIETHYLPROPION HYDROCHLORIDE
Recent Clinical Trials for DIETHYLPROPION HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlineN/A
New River PharmaceuticalsPhase 1/Phase 2

See all DIETHYLPROPION HYDROCHLORIDE clinical trials

Pharmacology for DIETHYLPROPION HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DIETHYLPROPION HYDROCHLORIDE
Synonyms for DIETHYLPROPION HYDROCHLORIDE
090D846
1-Phenyl-2-diethylaminopropanone-1 hydrochloride
1-Propanone, 2-(diethylamino)-1-phenyl-, hydrochloride
134-80-5
2-(Diethylamino)-1-phenyl-1-propanone Hydrochloride
2-(diethylamino)-1-phenyl-propan-1-one hydrochloride
2-(diethylamino)-1-phenylpropan-1-one hydrochloride
2-(Diethylamino)propiophenone hydrochloride
AC-16025
AC1L3M34
AKOS015962206
alpha-Benzoyltriethylamine hydrochloride
alpha-Benzoyltriethylammonium chloride
Amfepramon hydrochloride
Amfepramone (hydrochloride)
Amfepramone hydrochloride
Amphepramonum hydrochloride
AN-23092
AOB5348
API0005426
AS-16865
C-46079
C13H19NO.HCl
Cambridge id 5809497
CAS-134-80-5
CCG-220122
CHEBI:643703
CHEMBL1693
CS-4472
D03801
Diethylproion hydrochloride
Diethylpropion HCL
Diethylpropion hydrochloride (USP)
Diethylpropion hydrochloride [USAN]
Diethylpropion hydrochloride [USP]
Diethylpropion hydrochloride solution, 1.0 mg/mL in methanol (with 1% 1 M HCl; as free base), certified reference material
DSSTox_CID_27816
DSSTox_GSID_47838
DSSTox_RID_82580
DTXSID4047838
EINECS 205-156-5
HY-B0981
Lineal-Rivo
LS-125146
Magrex Retard
MCULE-2048650105
Menutil
Moderatan
NCGC00167475-01
NCGC00167475-02
Nu-Dispoz
Propiophenone, 2-(diethylamino)-, hydrochloride
rac Diethylpropion-d10 Hydrochloride
Regenon hydrochloride
SCHEMBL15483
SR-01000220674
SR-01000220674-1
SR-01000220674-2
Tenapil
Tenuate
Tenuate (TN)
Tenuate Dospan
Tenuate-Dospan
Tepanil Ten-tab
Tox21_112479
Tox21_112479_1

US Patents and Regulatory Information for DIETHYLPROPION HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 091680-001 Oct 24, 2011 AB RX No Yes   Start Trial   Start Trial   Start Trial
Sandoz DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 085916-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Chartwell Rx DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 088268-001 Aug 25, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Teva DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 088642-001 Sep 20, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Avanthi Inc DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 201212-001 Dec 22, 2010 AA RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Express Scripts
Merck
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.